Malignant fibrous histiocytoma of the extremity
β Scribed by Jonathan C. Salo; Jonathan J. Lewis; James M. Woodruff; Denis H. Leung; Murray F. Brennan
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 112 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND. This study examines prognostic factors and outcomes for a group of patients with malignant fibrous histiocytoma of the extremity treated at a single referral institution.
METHODS. A total of 239 patients underwent complete surgical excision between
July 1982 and July 1996 and were followed prospectively.
RESULTS.
The overall 5-year and 10-year disease specific survival rates for this group were 65% and 59%, respectively. Age ΟΎ50 years, tumor location, and presentation with local recurrence were all associated with increased risk of local recurrence. Tumor size, grade, depth, and presentation with local recurrence were all associated with adverse disease specific and metastasis free survival. Tumor size Υ10 cm was associated with a particularly unfavorable outcome.
CONCLUSIONS.
The majority of malignant fibrous histiocytomas of the extremity are associated with a relatively favorable prognosis. Size Υ5 cm, deep depth, and high grade are all unfavorable factors. Size Υ10 cm is associated with an even more unfavorable prognosis.
π SIMILAR VOLUMES
Malignant fibrous histiocytoma (MFH), arising at the site of a sacral chordoma 8 years after massive radiotherapy, is described. Initially, the patient received 7000 rad to the sacral area and, on recurrence, 5 years later, an additional 4000 rad. Two years later, a sacral mass was noted again. Biop